Development and validation of a HPLC method for determination of levonorgestrel and quinestrol in rat plasma.
Levonorgestrel and quinestrol, commonly known as EP-1, has long been used in the control of wild rodents. Up to the present time, however, no method for simultaneous quantification of levonorgestrel and quinestrol in rat plasma has been reported. In the present study, a sensitive reverse-phase high-performance liquid chromatography with ultraviolet detection (RP-HPLC-UV) method for quantification of levonorgestrel and quinestrol in rat plasma has been developed. It uses a Kromasil ODS C(18) column and acetonitrile-0.1% formic acid (85 : 15, v/v) mobile phase at ambient temperature. The plasma sample was prepared by hexane-isoamyl alcohol extraction (90 : 10, v/v). The flow rate and detection wavelength were 1.0 mL/min and 230 nm. The correlation coefficients were greater than 0.9995 within 0.08-50 microg/mL for levonorgestrel and 0.12-50 microg/mL for quinestrol, and the limits of detection were 0.02 and 0.05 microg/mL for levonorgestrel and quinestrol, respectively. Average recovery ranged from 92.5 to 96.3% and inter-day RSDs were less than 7.56%. This method can be applied to the further pharmacokinetic study of levonorgestrel and quinestrol in rat plasma.
Tang
Tao
T
College of Agriculture and Biotechnology, China Agricultural University, No. 2 Yuanmingyuan West Road, Beijing, China.
Li
Pingliang
P
Luo
Laixin
L
Shi
Dazhao
D
Li
Jianqiang
J
Cao
Yongsong
Y
D000818:Animals; D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D003276:Contraceptives, Oral / Q000097:blood*; D016912:Levonorgestrel / Q000097:blood*; D057230:Limit of Detection; D011800:Quinestrol / Q000097:blood*; D051381:Rats
D003276:Contraceptives, Oral; D016912:Levonorgestrel; D011800:Quinestrol